Non-allergic asthma as a CFTR-related disorder.

[1]  M. Claustres,et al.  Should diffuse bronchiectasis still be considered a CFTR-related disorder? , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[2]  A. Harris,et al.  Chromatin Dynamics in the Regulation of CFTR Expression , 2015, Genes.

[3]  V. Raia,et al.  Clinical expression of patients with the D1152H CFTR mutation. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[4]  Nicolas Molinari,et al.  Transcription factors and miRNAs that regulate fetal to adult CFTR expression change are new targets for cystic fibrosis , 2014, European Respiratory Journal.

[5]  M. Stuhrmann-Spangenberg,et al.  Handlungsempfehlung nach der Leitlinie „Diagnose der Mukoviszidose“ , 2014, Monatsschrift Kinderheilkunde.

[6]  M. Amaral,et al.  Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi , 2013, The FEBS journal.

[7]  George P Patrinos,et al.  Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene , 2013, Nature Genetics.

[8]  B. Kerem,et al.  Recommendations for the classification of diseases as CFTR-related disorders. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[9]  N. Derichs,et al.  New clinical diagnostic procedures for cystic fibrosis in Europe. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[10]  Milan Macek,et al.  Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport. , 2010, American journal of respiratory and critical care medicine.

[11]  L. Corcos,et al.  CELF proteins regulate CFTR pre-mRNA splicing: essential role of the divergent domain of ETR-3 , 2010, Nucleic acids research.

[12]  B. Kerem,et al.  Consensus on the Use and Interpretation of Cystic Fibrosis Mutation Analysis in Clinical Practice , 2022 .

[13]  K De Boeck,et al.  Cystic fibrosis: terminology and diagnostic algorithms , 2005, Thorax.

[14]  B. Kerem,et al.  Nasal potential difference measurements in patients with atypical cystic fibrosis. , 2001, The European respiratory journal.

[15]  B. Kerem,et al.  Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations. , 2000, Human molecular genetics.

[16]  J. Clancy,et al.  Nasal potential difference measurements to assess CFTR ion channel activity. , 2011, Methods in molecular biology.